🧬Microbiome Therapeutics
Therapeutics targeting the gut microbiome and its role in disease — live biotherapeutics and microbiome-based diagnostics.
Market Cap$148.6M
1D-2.38%
Companies84
Public Cos3
SECTOR MARKET CAP
$148.6M-98.4%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $76.9M | MCRB |
| 2 |  | Sweden | $67.2M | IBT-B.ST |
| 3 |  | United States | $4.5M | AZTR |